cT2期及以上肾皮质肿瘤部分肾切除术的价值:肾功能保留与术后并发症增加的风险-获益分析
本研究分析2000至2012年间1921例肾皮质肿瘤切除患者,其中297例临床分期T2及以上,比较部分肾切除术与根治性肾切除术在肾功能保留与术后并发症之间的风险-获益。结果显示,对于直径7至12cm的肿瘤,根治性肾切除术导致eGFR降级的风险高于部分肾切除术相关并发症的风险,且eGFR降级风险与并发症风险在所有肿瘤大小中幅度相似。结论提示部分肾切除术对cT2及以上肾肿瘤的eGFR保留优势抵消了其较高的并发症发生率。
要点
- 对于cT2期及以上肾皮质肿瘤,部分肾切除术的eGFR保留优势超过其并发症风险。
- 肿瘤直径7至12cm时,根治性肾切除术的eGFR降级风险高于部分肾切除术的并发症风险。
- eGFR降级风险与并发症风险在所有肿瘤大小中幅度相似。
核心结论
- 部分肾切除术对cT2期及以上肾肿瘤的eGFR保留优于根治性肾切除术,其优势幅度抵消了部分肾切除术较高的并发症发生率。
研究设计与样本
- 单中心回顾性分析,纳入2000至2012年间1921例肾皮质肿瘤切除术患者,其中297例临床分期T2及以上。
- 采用多因素logistic回归模型(校正年龄、肿瘤大小和合并症)分别计算根治性肾切除术和部分肾切除术的90天内并发症风险及低eGFR风险,并计算风险估计差值。
主要发现
- 对于直径7至12cm的肿瘤,根治性肾切除术相关的eGFR降级风险高于部分肾切除术相关的并发症风险。
- eGFR降级风险与并发症风险在所有肿瘤大小中幅度相似。
关键数值与推荐
- 部分肾切除术获益定义为术后1年eGFR≥60ml/min/1.73m2的保留。
- 并发症风险为90天内并发症风险;低eGFR风险为eGFR降级风险。
临床怎么用
- 对于cT2期及以上肾皮质肿瘤,部分肾切除术可更好地保留术后1年eGFR≥60ml/min/1.73m2,且其并发症风险不超过根治性肾切除术的eGFR降级风险。
局限性
- 分析为单中心研究。
- 仅使用肿瘤大小比较手术的风险和获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Indications for partial nephrectomy (PN) have expanded to include larger tumors. Compared with radical nephrectomy (RN), PN reduces the risk of chronic kidney disease but is associated with higher morbidity. OBJECTIVE: To explore whether the benefit of PN (preservation of estimated glomerular filtration rate [eGFR] ≥60ml/min/1.73m2 1yr postoperatively) over RN is offset by higher morbidity for cT2-cT3a tumors. DESIGN, SETTING, AND PARTICIPANTS: A total of 1921 patients with renal cortical tumors who underwent nephrectomy between 2000 and 2012 were analyzed, with 297 having clinical stage T2 or higher disease. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Multivariable logistic regression models adjusted for age, tumor size, and comorbidities were used to calculate the risk of complications within 90d and the risk of low eGFR across a range of tumor sizes. Models were created separately for RN and PN, and the difference between risk estimates was calculated. RESULTS AND LIMITATIONS: For tumors with diameters between 7 and 12cm, the risk of eGFR downgrade associated with RN was higher than the risk of complications associated with PN. The magnitude of the risk of eGFR downgrade was similar to the magnitude of complications risk across all tumor sizes. Our analysis was performed at a single institution, and used only tumor size to compare the risk and benefits of surgery. CONCLUSIONS: Our study suggests that PN is associated with higher eGFR preservation than RN for cT2 or greater renal tumors. The magnitude of this advantage offsets the higher morbidity observed with PN. PATIENT SUMMARY: When treating a large kidney tumor, it is difficult to decide whether it is better to remove the whole kidney or remove just the tumor. The second option improves postoperative renal function but is more complex. We tried to find whether there is a tumor size at which one technique should be used over the other.
引用
- Vilaseca A, Guglielmetti G, Vertosick EA, et al. Value of Partial Nephrectomy for Renal Cortical Tumors of cT2 or Greater Stage: A Risk-benefit Analysis of Renal Function Preservation Versus Increased Postoperative Morbidity. Eur Urol Oncol. 2019. PMID: 31411969. doi:10.1016/j.euo.2019.04.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。